FDA cracking down on fat-melting injections

Apr 07, 2010 By MATTHEW PERRONE , AP Business Writer

(AP) -- The Food and Drug Administration is cracking down on fat-melting injections used in spas across the U.S., saying the drugs have not been proven safe or effective.

Lipodissolve injections, a popular nonsurgical alternative to liposuction, are used to dissolve small fat deposits around the legs, arms and belly. The FDA said Wednesday the drugs have not been cleared by federal scientists, as required by law.

The agency issued warning letters to a half-dozen spas that offer the injections, citing them for making unsubstantiated claims about lipodissolve therapy.

"The claims made for your lipodissolve products are false and misleading in that they are not supported by substantial evidence or substantial clinical experience," states a letter to All About You Medspa in Madison, Ind.

Other spas cited by the FDA included: Pure Med Spa of Boca Raton, Fla., Monarch Med Spa of King of Prussia, Pa., and three others.

The Web site for Monarch Med Spa claims that, "Rather than go through the pain and discomfort associated with liposuction, patients now have the option of a series of injections with very minimal discomfort."

Calls to Monarch Med Spa were not immediately returned midday Wednesday.

FDA regulators called on the spas to stop using such claims and notify the agency within 15 working days of steps they are taking to correct the violations.

Spas that offer the injections say they are safe and effective. But safety advocates have called for proof and urge patients to think twice before paying thousands of dollars for an unproven procedure.

Some patients have complained of swelling, hard lumps and dark spots on their skin after receiving the therapy.

Lipodissolve and similar treatments use two chemicals, phosphatidylcholine, or PC, and sodium dioxycholate, or DC. Injections with the PC/DC mix aren't a treatment for obesity but a way to dissolve deposits of fat in certain areas.

Explore further: Drug for rare blood disorder developed at Penn receives orphan drug status from EU

4.3 /5 (3 votes)
add to favorites email to friend print save as pdf

Related Stories

FDA sends Procter & Gamble a warning

Sep 18, 2007

The U. S. Food and Drug Administration has warned the Procter & Gamble Co. about claims it makes for its Vicks Early Defense Foaming Hand Sanitizer.

Millennials' medspa influence

Jun 24, 2008

[B]Women ages 18-34 are empowering the medical spa trend but doing little to advocate their own safety within the facility[/B] The American Academy of Cosmetic Surgery has released its results from a consumer survey ask ...

FDA concerned about some STD medications

Mar 10, 2008

The U.S. Food and Drug Administration has warned six companies to stop marketing unapproved drugs for treating and preventing sexually transmitted diseases.

Recommended for you

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

Aug 21, 2014

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments : 0